WeCare-Life

Wecare Probiotics is a leading biotechnology company specializing in the research, development, and industrialization of probiotic strains and live biotherapeutic products (LBPs). The company maintains an extensive library of proprietary microbial strains and operates a comprehensive platform for strain screening, functional validation, and large-scale production. Wecare Probiotics serves the global pharmaceutical, nutraceutical, and food industries, offering high-activity probiotic powders and finished formulations for indications such as gastrointestinal health, metabolic disorders, and immune modulation. With advanced manufacturing capabilities including freeze-drying and microencapsulation, the company also provides CDMO services to international partners. Backed by prominent investors like Temasek and Goldman Sachs, Wecare Probiotics is a key innovator in the microbiome space, focusing on clinically-backed solutions for human health.